ranitidine

Generic: ranitidine

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ranitidine
Generic Name ranitidine
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ranitidine hydrochloride 150 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 64980-636
Product ID 64980-636_b4d3aa30-82b1-45e5-89bb-829c5ccf7ffe
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211289
Listing Expiration 2026-12-31
Marketing Start 2025-12-06

Pharmacologic Class

Classes
histamine h2 receptor antagonists [moa] histamine-2 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64980636
Hyphenated Format 64980-636

Supplemental Identifiers

RxCUI
198191 198193
UPC
0364980637039
UNII
BK76465IHM

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ranitidine (source: ndc)
Generic Name ranitidine (source: ndc)
Application Number ANDA211289 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (64980-636-03)
source: ndc

Packages (1)

Ingredients (1)

ranitidine hydrochloride (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b4d3aa30-82b1-45e5-89bb-829c5ccf7ffe", "openfda": {"upc": ["0364980637039"], "unii": ["BK76465IHM"], "rxcui": ["198191", "198193"], "spl_set_id": ["0fba6615-37c2-4ba6-b6e5-09599369a5bc"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (64980-636-03)", "package_ndc": "64980-636-03", "marketing_start_date": "20251206"}], "brand_name": "RANITIDINE", "product_id": "64980-636_b4d3aa30-82b1-45e5-89bb-829c5ccf7ffe", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "64980-636", "generic_name": "RANITIDINE", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RANITIDINE", "active_ingredients": [{"name": "RANITIDINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA211289", "marketing_category": "ANDA", "marketing_start_date": "20251206", "listing_expiration_date": "20261231"}